Abstract

Four novel copper complexes bis((E)-2-((4-phenoxyphenylimino)methyl)phenolate) copper(II) (CuL1), bis((E)-2-((4-(4-biphenyloxy)phenylimino)methyl)phenolate) copper(II) (CuL2), bis((E)-2-((4-(naphthalen-1-yloxy)phenylimino)methyl)phenolate) copper(II) (CuL3) and bis((E)-2-((4-(2-naphthoxy)phenylimino)methyl)phenolate) copper(II) (CuL4) have been synthesized and characterized by FTIR spectroscopy, elemental analysis and electro-analytical techniques. Single crystal X-ray diffraction analysis of complex (CuL1) revealed that the compound crystallizes in the orthorhombic crystal system. The absolute structure has been determined from the diffraction data. The molecule lies on a 2-fold axis with geometry intermediate between square planar and tetrahedral. In the complexes the ligands are bidentate, coordinating through phenolate oxygen and azomethine nitrogen to the copper ions. The biological studies (cytotoxic and antitumor) have revealed their bioactive nature. Results of brine shrimp cytotoxicity indicated their LD50 values <1μg/ml and IC50 values from 0.7 to 16μg/ml, indicating their antitumor nature. The voltammetric analysis showed that the complexes follow one electron transfer quasi-reversible partially diffusion controlled process. Further, the electro-reduced form of the complexes had substantial interaction with DNA molecules in a concentration dependent manner.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.